proteanTecs
PrivateLast Round
Series D
Sep 9, 2025
Est. Valuation
$300M
Total Funding Raised
$247M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
proteanTecs operates in AI, Data & Cloud Infrastructure and is based in Haifa. Its latest recorded funding round was a Series D round in September 2025.
proteanTecs is an industrial technology company that provides deep data analytics for electronics health and performance monitoring through cloud-based solutions and on-chip telemetry.
Sector
AI, Data & Cloud Infrastructure
Verticals
Semiconductors, Sensors, Cloud Infrastructure, Autonomous Vehicles
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
proteanTecs Comparables
Compare proteanTecs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PDF Solutions | 78% | |
| Synopsys | 76% | |
| Siemens | 74% |
For institutional investors. Book with your work email.
proteanTecs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Sep 9, 2025 | ||||
| Series D | May 10, 2022 | ||||
| Series C Extension | Sep 23, 2021 | ||||
| Series C | Aug 27, 2020 | ||||
| Series B | Apr 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
proteanTecs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Addition | Series D |
| IAG Capital Partners | Series D |
| Atreides Management | Series C |
| Allied Group | Series D, Series C Extension |
| WRVI Capital | Series B |
| Mitsubishi UFJ Asset Management | Series B |
| ITI Venture Capital Partners | Series C, Series B, Series C Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 183% MoM, reaching 19.2K.
- Nov 18, 2025
Noritaka Kojima appointed General Manager & Country Manager for Japan.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- expands_offices_inNov 5, 2026
ProteanTecs Ltd. expands its presence in Japan as Toshifumi Kaneko provides strategic guidance for its high-compute, autonomous, AI-driven solutions.
- hiresNov 5, 2026
ProteanTecs Ltd. appoints Mr. Kaneko to its expanding Advisory Board to deepen engagement with Japanese enterprises through co-development, proof-of-concept initiatives, and mass-production support.
- partners_withSep 4, 2026
ProteanTecs Ltd. and MegaChips Corporation collaborate to integrate embedded monitoring technology into next-generation ASIC and LSI digital systems, improving visibility into chip health, performance, and reliability.
- launchesAug 19, 2026
ProteanTecs Ltd. unveils a dedicated suite of health, power and performance management solutions for multi-die systems that provides chiplet-level visibility and supports yield, reliability and power-performance optimization on Aug 19th '26.
For institutional investors. Book with your work email.
proteanTecs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about proteanTecs's valuation, stock price, and market status.
Is proteanTecs a public or private company?
proteanTecs is a private company.
What is the current stock price of proteanTecs?
proteanTecs is a private company, so its shares have no public market price. Caplight tracks proteanTecs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is proteanTecs worth (valuation)?
proteanTecs's valuation is estimated at $300.0M based on funding round data.
Can I buy proteanTecs stock?
proteanTecs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was proteanTecs's last funding round?
proteanTecs's most recent funding round was Series D on September 9, 2025.
Who are the main investors in proteanTecs?
Key investors in proteanTecs include IAG Capital Partners, WRVI Capital, Koch Disruptive Technologies, Viola Ventures, Redline Capital Management.
Will proteanTecs IPO soon?
No public IPO plans have been announced for proteanTecs.
How can I track proteanTecs secondary market activity?
Caplight tracks bids, offers, and trades in proteanTecs's shares on secondary markets.